Myrodia Therapeutics Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • Private

  • Employees
  • 10

Employees

  • Latest Deal Type
  • Seed

  • Investors
  • 3

Myrodia Therapeutics General Information

Description

Operator of a biotechnology company intended to develop preventive and therapeutic drugs using odorous components. The company specializes in developing pharmaceutical seeds and unlocking life-saving potential by inducing artificial hibernation, providing treatment options for patients suffering from emergency diseases.

Contact Information

Website
www.myrodiatx.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 4th Floor, Toko Building
  • 4-11-1 Nihonbashi Honcho, Chuo-ku
  • Tokyo
  • Japan
Primary Industry
Drug Discovery
Other Industries
Other Pharmaceuticals and Biotechnology
Vertical(s)
Life Sciences
Corporate Office
  • 4th Floor, Toko Building
  • 4-11-1 Nihonbashi Honcho, Chuo-ku
  • Tokyo
  • Japan

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Myrodia Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Seed Round 01-Nov-2019 Completed Generating Revenue
To view Myrodia Therapeutics’s complete valuation and funding history, request access »

Myrodia Therapeutics Patents

  • 4

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • 3

    Pending

  • Expiring in next 12 mo

Myrodia Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4524132-A1 2-methyl-2-thiazoline salt Pending 10-May-2022
EP-4524132-A4 2-methyl-2-thiazoline salt Pending 10-May-2022
US-20250304540-A1 2-methyl-2-thiazoline salt Pending 10-May-2022
WO-2023219106-A1 2-methyl-2-thiazoline salt Inactive 10-May-2022 C07D277/10

Myrodia Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Myrodia Therapeutics Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
ANRI Venture Capital Minority
Remiges Ventures Venture Capital Minority
Taiho Innovations Corporate Venture Capital Minority
To view Myrodia Therapeutics’s complete investors history, request access »

Ready to get started?

Request a free trial

Myrodia Therapeutics FAQs

  • When was Myrodia Therapeutics founded?

    Myrodia Therapeutics was founded in 2019.

  • Where is Myrodia Therapeutics headquartered?

    Myrodia Therapeutics is headquartered in Tokyo, Japan.

  • What is the size of Myrodia Therapeutics?

    Myrodia Therapeutics has 10 total employees.

  • What industry is Myrodia Therapeutics in?

    Myrodia Therapeutics’s primary industry is Drug Discovery.

  • Is Myrodia Therapeutics a private or public company?

    Myrodia Therapeutics is a Private company.

  • What is Myrodia Therapeutics’s current revenue?

    The current revenue for Myrodia Therapeutics is .

  • Who are Myrodia Therapeutics’s investors?

    ANRI, Remiges Ventures, and Taiho Innovations have invested in Myrodia Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process